These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 27061975

  • 1. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
    Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM.
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
    [Abstract] [Full Text] [Related]

  • 2. Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents.
    Rockstroh JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA.
    HIV Clin Trials; 2015 Oct; 16(2):72-80. PubMed ID: 25923596
    [Abstract] [Full Text] [Related]

  • 3. Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.
    Lazzarin A, Than S, Valluri SR, Heera J, Mukwaya G.
    HIV Clin Trials; 2012 Oct; 13(2):83-9. PubMed ID: 22510355
    [Abstract] [Full Text] [Related]

  • 4. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y, Duan S, Ye R, Yang Y, Yao S, Wang J, Cao D, Liu X, Lu L, Jia M, Wu Z, He N.
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [Abstract] [Full Text] [Related]

  • 5. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S, Fairley CK, Sasadeusz J, He J, Wei X, Zeng H, Jing J, Mao L, Chen X, Zhang L.
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [Abstract] [Full Text] [Related]

  • 6. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T, Deschenes M, Lebouché B, Benmassaoud A, Sewitch M, Ghali P, Wong P, Halme A, Vuille-Lessard E, Pexos C, Klein MB, Sebastiani G.
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [Abstract] [Full Text] [Related]

  • 7. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
    Bailey H, Nizova N, Martsynovska V, Volokha A, Malyuta R, Cortina-Borja M, Thorne C, Ukraine European Collaborative Study in EuroCoord.
    BMC Infect Dis; 2016 Dec 12; 16(1):755. PubMed ID: 27955711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavir.
    Palacios R, Vergara S, Rivero A, Aguilar I, Macías J, Camacho A, Lozano F, García-Lázaro M, Pineda JA, Torre-Cisneros J, Márquez M, Santos J.
    HIV Clin Trials; 2006 Dec 12; 7(6):319-23. PubMed ID: 17197379
    [Abstract] [Full Text] [Related]

  • 10. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K, Mira JA, Ruiz-Morales J, Rivero A, Collado A, Torres-Cornejo A, Merino D, de Los Santos-Gil I, Macías J, González-Serrano M, Camacho A, Parra-García G, Pineda JA, SEGURIDAD HEPÁTICA Study Team of the Grupo HEPAVIR de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).
    J Antimicrob Chemother; 2011 Nov 12; 66(11):2605-14. PubMed ID: 21903660
    [Abstract] [Full Text] [Related]

  • 11. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
    Boyd A, Bottero J, Miailhes P, Lascoux-Combe C, Rougier H, Girard PM, Serfaty L, Lacombe K.
    J Int AIDS Soc; 2017 Feb 28; 20(1):21426. PubMed ID: 28362068
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M, Wong WW, Law MG, Kiertiburanakul S, Yunihastuti E, Merati TP, Lim PL, Chaiwarith R, Phanuphak P, Lee MP, Kumarasamy N, Saphonn V, Ditangco R, Sim BL, Nguyen KV, Pujari S, Kamarulzaman A, Zhang F, Pham TT, Choi JY, Oka S, Kantipong P, Mustafa M, Ratanasuwan W, Durier N, Chen YM.
    PLoS One; 2016 Feb 28; 11(3):e0150512. PubMed ID: 26933963
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute liver enzyme elevations in HIV-1-infected patients.
    Livry C, Binquet C, Sgro C, Froidure M, Duong M, Buisson M, Grappin M, Quantin C, Portier H, Chavanet P, Piroth L.
    HIV Clin Trials; 2003 Feb 28; 4(6):400-10. PubMed ID: 14628283
    [Abstract] [Full Text] [Related]

  • 17. The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi.
    Andreotti M, Pirillo MF, Liotta G, Jere H, Maulidi M, Sagno JB, Luhanga R, Amici R, Mancini MG, Gennaro E, Marazzi MC, Vella S, Giuliano M, Palombi L, Mancinelli S.
    BMC Infect Dis; 2014 Apr 04; 14():180. PubMed ID: 24708626
    [Abstract] [Full Text] [Related]

  • 18. Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.
    Clotet B, Clumeck N, Katlama C, Nijs S, Witek J.
    J Antimicrob Chemother; 2010 Nov 04; 65(11):2450-4. PubMed ID: 20801782
    [Abstract] [Full Text] [Related]

  • 19. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
    Yu G, Chi X, Wu R, Wang X, Gao X, Kong F, Feng X, Gao Y, Huang X, Jin J, Qi Y, Tu Z, Sun B, Zhong J, Pan Y, Niu J.
    PLoS One; 2015 Nov 04; 10(9):e0139015. PubMed ID: 26422607
    [Abstract] [Full Text] [Related]

  • 20. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
    Abad-Fernández M, Moreno A, Dronda F, del Campo S, Quereda C, Casado JL, Pérez-Elías MJ, Moreno S, Vallejo A.
    AIDS; 2015 Feb 20; 29(4):401-9. PubMed ID: 25565497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.